2B8T2M, A Novel Fusion of ALT-803, an IL-15 Superagonist, with 4 Single-Chains of Anti-CD20 Antibody Significantly Enhanced Expanded Natural Killer Cells Ctotoxicity Against Rituximab Sensitive and Resistant Burkitt Lymphoma (BL)
Document Type
Abstract
Publication Date
9-2018
Journal Title
British Journal of Haematology
Department
Pediatrics
Second Department
Health Behavior and Community Health
Recommended Citation
Chu, Y., Su, N., Jeng, E. K., Alter, S., Rhode, P. R., Nayyar, G., Barth, M., Lee, D. A., Wong, H. C., & Cairo, M. S. (2018). 2B8T2M, A Novel Fusion of ALT-803, an IL-15 Superagonist, with 4 Single-Chains of Anti-CD20 Antibody Significantly Enhanced Expanded Natural Killer Cells Ctotoxicity Against Rituximab Sensitive and Resistant Burkitt Lymphoma (BL). British Journal of Haematology, 182 (Suppl. 1), 46-47. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/227
COinS
